Skip to search.
 FTSE 100 Down 1.27%

More On SKP.L

Quotes

Derivatives

  • Warrants
  • Investment Products

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Skyepharma PLC (SKP.L)

-LSE Ticker: 3BFNB6/ISIN: GB00B3BFNB64
469.80 Down 8.70(1.82%) 29 Apr 16:00
Prev Close:478.50
Open:472.00
Bid:469.25 x 88800
Ask:469.75 x 248000
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:467.75 - 486.25
52wk Range:249.25 - 486.25
Volume:67,598
Avg Vol (3m):303,522
Market Cap:497.09m
P/E (ttm):30.31
EPS (ttm):15.50
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in GBp.

Key Statistics

Forward P/E (1 yr):0.18
P/S (ttm):625.27
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :19.75
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Skyepharma PLC develops and sells oral and inhalation pharmaceutical products worldwide. The company’s inhalation products include flutiform, an inhalation drug for asthma; and Relvar Ellipta/Breo Ellipta, Anoro Ellipta, and Incruse Ellipta, ... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback